[show abstract] [hide abstract]
ABSTRACT: Outlining the treatment for an unclassifiable lymphoid malignancy is often difficult. A highly undifferentiated lymphomatous mass that relapsed in spite of intense chemotherapy and autologous transplant is reported. At relapse, there was differentiation into myeloid lineage. Though remission was achieved with AML-type reinduction chemotherapy, the mass recurred post allogenic cord blood stem cell transplant.
Pediatric Hematology and Oncology 04/2009; 26(2):93-9. · 0.90 Impact Factor